Stay updated on BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer
Sign up to get notified when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.

Latest updates to the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed descriptions of a Phase 2 clinical trial for metastatic kidney cancer and the addition of a new version revision number. The name 'BIONIKK' has been added, while the previous version's content regarding the disease and treatment protocols has been deleted.SummaryDifference30%
- Check20 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check28 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check64 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check78 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
- Check85 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
Stay in the know with updates to BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer
Enter your email address, and we'll notify you when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.